We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+2.43%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$8.8B
AUM Growth
+$346M
(+4.1%)
Cap. Flow
+$350M
Cap. Flow
% of AUM
3.97%
Top 10 Holdings %
Top 10 Hldgs %
18.46%
Holding
1,111
New
53
Increased
455
Reduced
293
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$77.4M |
| 2 |
AT&T
T
|
+$35.6M |
| 3 |
Deutsche Bank
DB
|
+$33.1M |
| 4 |
S&P Global
SPGI
|
+$25M |
| 5 |
Texas Instruments
TXN
|
+$24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$37.1M |
| 2 |
HCA Healthcare
HCA
|
+$24.6M |
| 3 |
American Water Works
AWK
|
+$23.9M |
| 4 |
UBS Group
UBS
|
+$18.4M |
| 5 |
Manulife Financial
MFC
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.43% |
| 2 | Financials | 14.33% |
| 3 | Communication Services | 12.73% |
| 4 | Technology | 11.92% |
| 5 | Consumer Staples | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Supernus Pharmaceuticals
SUPN
$2.77B
| $516K | 0.01% |
26,000
+5,000
| +24% | +$88.7K |
|
|
JNPR
677
DELISTED
Juniper Networks
JNPR
| $510K | 0.01% |
23,077
-325,200
| -93% | -$7.57M |
|
|
HTS
678
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $506K | 0.01% |
31,053
| – | – |
|
679
Capitol Federal Financial
CFFN
$1.1B
| $501K | 0.01% |
36,761
| – | – |
|
680
MacroGenics
MGNX
$257M
| $498K | 0.01% |
18,500
+3,700
| +25% | +$83.4K |
|
|
SAGE
681
DELISTED
Sage Therapeutics
SAGE
| $497K | 0.01% |
16,950
+3,100
| +22% | +$103K |
|
|
SCG
682
DELISTED
Scana
SCG
| $497K | 0.01% |
6,668
+1,600
| +32% | +$112K |
|
683
ManpowerGroup
MAN
$2.63B
| $491K | 0.01% |
7,777
-1,900
| -20% | -$147K |
|
684
Oneok
OKE
$54.5B
| $485K | 0.01% |
10,280
+4,016
| +64% | +$159K |
|
685
Jones Lang LaSalle
JLL
$16.7B
| $480K | 0.01% |
4,894
+900
| +23% | +$103K |
|
686
Repligen
RGEN
$9.25B
| $479K | 0.01% |
18,000
+3,800
| +27% | +$97.2K |
|
|
DERM
687
DELISTED
Dermira, Inc.
DERM
| $477K | 0.01% |
15,950
+3,150
| +25% | +$86.9K |
|
|
INSY
688
DELISTED
Insys Therapeutics, Inc.
INSY
| $477K | 0.01% |
38,100
+7,100
| +23% | +$103K |
|
|
VRN
689
DELISTED
Veren
VRN
| $476K | 0.01% |
30,200
-2,200
| -7% | -$35.3K |
|
690
Sarepta Therapeutics
SRPT
$1.77B
| $462K | 0.01% |
24,733
+5,250
| +27% | +$97.2K |
|
691
Willis Towers Watson
WTW
$32B
| $459K | 0.01% |
3,730
| – | – |
|
|
LMNX
692
DELISTED
Luminex Corp
LMNX
| $457K | 0.01% |
23,000
+4,500
| +24% | +$90.1K |
|
|
GHDX
693
DELISTED
Genomic Health, Inc.
GHDX
| $457K | 0.01% |
17,400
+3,400
| +24% | +$90.3K |
|
694
Host Hotels & Resorts
HST
$16B
| $456K | 0.01% |
28,440
-10,000
| -26% | -$157K |
|
695
SEI Investments
SEIC
$12.6B
| $456K | 0.01% |
9,740
+6,300
| +183% | +$303K |
|
696
Mattel
MAT
$4.23B
| $452K | 0.01% |
14,560
-1,800
| -11% | -$57.1K |
|
697
Essex Property Trust
ESS
$18.5B
| $451K | 0.01% |
2,000
| – | – |
|
698
KB Financial Group
KB
$43.5B
| $450K | 0.01% |
15,802
+1,800
| +13% | +$52.2K |
|
|
AMAG
699
DELISTED
AMAG Pharmaceuticals
AMAG
| $445K | 0.01% |
18,650
+3,700
| +25% | +$84.8K |
|
|
TLN
700
DELISTED
Talen Energy Corporation
TLN
| $445K | 0.01% |
32,910
+32,661
| +13,117% | +$400K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q2 2016 Portfolio in Review
As of Q2 2016, DekaBank Deutsche Girozentrale held 1,111 positions worth $8.8B, up 4.1% from $8.45B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
DekaBank Deutsche Girozentrale deployed $350M of net new capital in Q2 2016, opening 53 new positions and adding to 455 existing holdings. Its largest new stake was S&P Global: 232,858 shares worth $24.7M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was HCA Healthcare, an estimated $24.6M trimmed.
- DekaBank Deutsche Girozentrale's largest Q2 2016 buy was S&P Global: 232,858 shares worth $24.7M.
- DekaBank Deutsche Girozentrale added most to Charter Communications in Q2 2016, an estimated $77.4M increase.
- DekaBank Deutsche Girozentrale's biggest Q2 2016 reduction was HCA Healthcare, cutting an estimated $24.6M.
- DekaBank Deutsche Girozentrale fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $37.1M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 18% of its $8.8B portfolio in Q2 2016.
- DekaBank Deutsche Girozentrale opened 53 new positions and closed 123 in Q2 2016.
- DekaBank Deutsche Girozentrale's portfolio value rose 4.1% quarter-over-quarter to $8.8B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.